| Ident. | Authors (with country if any) | Title |
|---|
| 000006 |
Martina Wollenhaupt [Suisse] ; Abhijeeth Chandrasekaran [Inde] ; Danitza Tomianovic [Suisse] | The safety of oseltamivir in pregnancy: an updated review of post-marketing data |
| 000059 |
Alexander H. Flannery [États-Unis] ; Melissa L. Thompson Bastin [États-Unis] | Oseltamivir Dosing in Critically III Patients With Severe Influenza |
| 000085 |
Natalia A. Ilyushina [États-Unis] ; Raymond P. Donnelly [États-Unis] | In vitro anti-influenza A activity of interferon (IFN)-λ1 combined with IFN-β or oseltamivir carboxylate |
| 000132 |
Wei-Yu Chen [Taïwan] ; Chia-Jung Lin [Taïwan] ; Chung-Min Liao [Taïwan] | Assessing exposure risks for aquatic organisms posed by Tamiflu use under seasonal influenza and pandemic conditions |
| 000144 |
LAN HUANG [République populaire de Chine] ; YANG CAO [République populaire de Chine] ; JIANFANG ZHOU [République populaire de Chine] ; KUN QIN [République populaire de Chine] ; WENFEI ZHU [République populaire de Chine] ; YUN ZHU [République populaire de Chine] ; LEI YANG [République populaire de Chine] ; DAYAN WANG [République populaire de Chine] ; HONG WEI [République populaire de Chine] ; YUELONG SHU [République populaire de Chine] | A Conformational Restriction in the Influenza A Virus Neuraminidase Binding Site by R152 Results in a Combinational Effect of I222T and H274Y on Oseltamivir Resistance |
| 000226 |
Clyde Dapat [Japon] ; Hiroki Kondo [Japon] ; Isolde C. Dapat [Japon] ; Tatiana Baranovich [Japon] ; Yasushi Suzuki [Japon] ; Yugo Shobugawa [Japon] ; Kousuke Saito [Japon] ; Reiko Saito [Japon] ; Hiroshi Suzuki [Japon] | Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan |
| 000235 |
Hui-Wen Chen [États-Unis, Taïwan] ; JENNA XIAO CHENG [États-Unis] ; Ming-Tsan Liu [Taïwan] ; Kevin King [États-Unis] ; Ju-Yi Peng [Taïwan] ; Xin-Quan Zhang [États-Unis] ; Ching-Ho Wang [Taïwan] ; Sujan Shresta [États-Unis] ; Robert T. Schooley [États-Unis] ; Yu-Tsueng Liu [États-Unis] | Inhibitory and combinatorial effect of diphyllin, a v-ATPase blocker, on influenza viruses |
| 000237 |
Chang-Wei Hsueh [Taïwan] ; Hui-Ming Yu [Taïwan] ; Huan-Sheng Chen [Taïwan] ; Chin-Pyng Wu [Taïwan] | Influenza-Related Postinfectious Encephalomyelitis Complicated by a Perforated Peptic Ulcer |
| 000238 |
Mélanie Samson [Canada] ; Andres Pizzorno [Canada] ; Yacine Abed [Canada] ; Guy Boivin [Canada] | Influenza virus resistance to neuraminidase inhibitors |
| 000307 |
Emanuel Haasbach [Allemagne] ; Carmen Hartmayer [Allemagne] ; Oliver Planz [Allemagne] | Combination of MEK inhibitors and oseltamivir leads to synergistic antiviral effects after influenza A virus infection in vitro |
| 000316 |
Jeroen J. A. Van Kampen [Pays-Bas] ; Astrid J. Bielefeld-Buss [Pays-Bas] ; Alewijn Ott [Pays-Bas] ; Jolanda Maaskant [Pays-Bas] ; Harald J. Faber [Pays-Bas] ; Johan G. Lutisan [Pays-Bas] ; Charles A. B. Boucher [Pays-Bas] | Case Report: Oseltamivir-Induced Resistant Pandemic Influenza A (H1N1) Virus Infection in a Patient With AIDS and Pneumocystis jirovecii Pneumonia |
| 000320 |
Andrew D. Mosholder [États-Unis] ; Judith A. Racoosin [États-Unis] ; Stephanie Young [États-Unis] ; Michael Wernecke [États-Unis] ; Azadeh Shoaibi [États-Unis] ; Thomas E. Macurdy [États-Unis] ; Christopher Worrall [États-Unis] ; Jeffrey A. Kelman [États-Unis] | Bleeding Events Following Concurrent Use of Warfarin and Oseltamivir by Medicare Beneficiaries |
| 000328 |
Elena A. Govorkova [États-Unis] ; Tatiana Baranovich [États-Unis] ; Patrick Seiler [États-Unis] ; Jianling Armstrong [États-Unis] ; Andrew Burnham [États-Unis] ; YI GUAN [République populaire de Chine] ; Malik Peiris [République populaire de Chine] ; Richard J. Webby [États-Unis] ; Robert G. Webster [États-Unis] | Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002-2012 shows need for continued monitoring |
| 000376 |
TRONG TUAN DAO [Corée du Sud] ; THAI TRUNG DANG [Corée du Sud] ; PHI HUNG NGUYEN [Corée du Sud] ; Eunhee Kim [Corée du Sud] ; PHUONG THIEN THUONG [Namibie] ; WON KEUN OH [Corée du Sud] | Xanthones from Polygala karensium inhibit neuraminidases from influenza A viruses |
| 000416 |
WAI LAN WU [Hong Kong] ; Siu-Ying Lau [Hong Kong] ; YIXIN CHEN [République populaire de Chine] ; GENYAN WANG [République populaire de Chine] ; Bobo Wing-Yee Mok [Hong Kong] ; XI WEN [Hong Kong] ; PUI WANG [Hong Kong] ; WENJUN SONG [Hong Kong] ; TIANWEI LIN [République populaire de Chine] ; Kwok-Hung Chan [Hong Kong] ; Kwok-Yung Yuen [Hong Kong] ; HONGLIN CHEN [Hong Kong, République populaire de Chine] | The 2008-2009 H1N1 influenza virus exhibits reduced susceptibility to antibody inhibition: Implications for the prevalence of oseltamivir resistant variant viruses |
| 000448 |
Y. H. Leung [Hong Kong] ; W. L. Lim [Hong Kong] ; M. H. Wong [Hong Kong] ; S. K. Chuang [Hong Kong] | SHORT REPORT Delayed oseltamivir treatment is associated with longer viral shedding of pandemic (H1N1) 2009 virus |
| 000486 |
Elodie Ghedin [États-Unis] ; Edward C. Holmes [États-Unis] ; Jay V. Depasse [États-Unis] ; Lady Tatiana Pinilla [Canada] ; Adam Fitch [États-Unis] ; Marie-Eve Hamelin [Canada] ; Jesse Papenburg [Canada] ; Guy Boivin [Canada] | Presence of Oseltamivir-Resistant Pandemic A/H1N1 Minor Variants Before Drug Therapy With Subsequent Selection and Transmission |
| 000514 |
Heather B. Miller [États-Unis] ; Remedios B. Gose [États-Unis] ; Mark T. Nagata [États-Unis] ; Rebecca H. Sciulli [États-Unis] ; A. Christian Whelen [États-Unis] | Pacific region influenza surveillance for oseltamivir resistance |
| 000519 |
A. Meijer [Pays-Bas] ; M. Jonges [Pays-Bas] ; P. Van Beek [Pays-Bas] ; C. M. Swaan [Pays-Bas] ; A. D. Osterhaus [Pays-Bas] ; R. S. Daniels [Royaume-Uni] ; A. C. Hurt [Australie] ; M. P. Koopmans [Pays-Bas] | Oseltamivir-resistant influenza A(H1N1)pdm09 virus in Dutch travellers returning from Spain, August 2012 |
| 000520 |
Afroditi Kourti [Grèce] ; Gregory Spanakos [Grèce] ; Leda Politi [Grèce] ; Anastasia Stavropoulou [Grèce] ; Nicholas Spanakis [Grèce] ; Athanassios Tsakris [Grèce] | Oseltamivir-resistant influenza A(H1N1) 2009 virus in Greece during the post-pandemic 2010-2011 season |
| 000521 |
Luis Meave Gutierrez-Mendoza [Mexique] ; Brian Schwartz [Canada] ; José De Jésus Mendez De Lira [Mexique] ; Veronika J. Wirtz [Mexique] | Oseltamivir storage, distribution and dispensing following the 2009 H1N1 influenza outbreak in Mexico |
| 000522 |
Lydia M. Upjohn [Australie] ; Andrew J. Stewardson [Australie] ; Caroline Marshall [Australie] | Oseltamivir adherence and tolerability in health care workers treated prophylactically after occupational influenza exposure |
| 000533 |
Katja Bauer [Allemagne] ; Ralf Dürrwald [Allemagne] ; Michael Schlegel [Allemagne] ; Kathrin Pfarr [Allemagne] ; Dominik Topf Nadine Wiesener [Allemagne] ; Hans-Martin Dahse [Allemagne] ; Peter Wutzler [Allemagne] ; Michaela Schmidtke [Allemagne] | Neuraminidase inhibitor susceptibility of swine influenza A viruses isolated in Germany between 1981 and 2008 |
| 000541 |
Rosaria Arvia [Italie] ; Fabiana Corcioli [Italie] ; Lisa Simi [Italie] ; Claudio Orlando [Italie] ; Riccardo De Santis [Italie] ; Marzia Facchini [Italie] ; Isabella Donatelli [Italie] ; Alberta Azzi [Italie] | Monitoring the susceptibility to oseltamivir of Influenza A(H1N1) 2009 virus by nested-PCR and pyrosequencing during the pandemic and in the season 2010-2011 |
| 000568 |
J. C. Rahamat-Langendoen [Pays-Bas] ; E. D. Tutuhatunewa [Pays-Bas] ; E. H. Schölvinck [Pays-Bas] ; E. Hak [Pays-Bas] ; M. Koopmans [Pays-Bas] ; H. G. M. Niesters [Pays-Bas] ; A. Riezebos-Brilman [Pays-Bas] | Influenza in the immediate post-pandemic era: A comparison with seasonal and pandemic influenza in hospitalized patients |
| 000587 |
Jennifer L. Mckimm-Breschkin [Australie] ; Christina Rootes [Australie] ; Peter G. Mohr [Australie] ; Susan Barrett [Australie] ; Victor A. Streltsov [Australie] | In vitro passaging of a pandemic H1N1/09 virus selects for viruses with neuraminidase mutations conferring high-level resistance to oseltamivir and peramivir, but not to zanamivir |
| 000594 |
Florian Lemaitre [France] ; Charles-Edouard Luyt [France] ; François Roullet-Renoleau [France] ; Ania Nieszkowska [France] ; Noël Zahr [France] ; Emmanuel Corvol [France] ; Christine Fernandez [France] ; Marie Antignac [France] ; Robert Farinotti [France] ; Alain Combes [France] | Impact of Extracorporeal Membrane Oxygenation and Continuous Venovenous Hemodiafiltration on the Pharmacokinetics of Oseltamivir Carboxylate in Critically III Patients With Pandemic (H1N1) Influenza |
| 000620 |
Olivier Ferraris [France] ; Vanessa Escuret [France] ; Maude Bouscambert [France] ; Jean-Sébastien Casalegno [France] ; Frederic Jacquot [France] ; Herve Raoul [France] ; Valérie Caro [France] ; Martine Valette [France] ; Bruno Lina [France] ; Michele Ottmann [France] | H1N1 influenza A virus neuraminidase modulates infectivity in mice |
| 000632 |
B. Wang [Australie] ; J. Taylor [Australie] ; M. Ratnamohan [Australie] ; K. Mcphie [Australie] ; A. Kesson [Australie] ; R. Dixit [Australie] ; R. Booy [Australie] ; A. C. Hurt [Australie] ; N. K. Saksena [Australie] ; D. E. Dwyer [Australie] | Frequency of oseltamivir resistance in Sydney, during the Newcastle outbreak of community transmitted oseltamivir-resistant influenza A(H1N1)pdm09 virus, Australia, June to August 2011 |
| 000659 |
Christopher W. Seibert [États-Unis] ; Saad Rahmat [États-Unis] ; Florian Krammer [États-Unis] ; Peter Palese [États-Unis] ; Nicole M. Bouvier [États-Unis] | Efficient Transmission of Pandemic H1N1 Influenza Viruses with High-Level Oseltamivir Resistance |
| 000682 |
Tohru Miyoshi-Akiyama [Japon] ; Yuki Akasaka [Japon] ; Teruko Oogane [Japon] ; Yuji Kondo [Japon] ; Takeji Matsushita [Japon] ; Keiji Funatogawa [Japon] ; Teruo Kirikae [Japon] | Development and evaluation of a line probe assay for rapid typing of influenza viruses and detection of the H274Y mutation |
| 000696 |
Tara A. Lavelle [Maroc, États-Unis] ; Timothy M. Uyeki [États-Unis] ; Lisa A. Prosser [États-Unis] | Cost-Effectiveness of Oseltamivir Treatment for Children with Uncomplicated Seasonal Influenza |
| 000706 |
Diana D. Y. Wong [Hong Kong] ; Ka-Tim Choy [Hong Kong] ; Renee W. Y. Chan [Hong Kong] ; SIN FUN SIA [Hong Kong] ; Hsin-Ping Chiu [Hong Kong] ; Peter P. H. Cheung [Hong Kong] ; Michael C. W. Chan [Hong Kong] ; J. S. Malik Peiris [Hong Kong] ; Hui-Ling Yen [Hong Kong] | Comparable Fitness and Transmissibility between Oseltamivir-Resistant Pandemic 2009 and Seasonal H1N1 Influenza Viruses with the H275Y Neuraminidase Mutation |
| 000712 |
B. Mohty [Suisse] ; Y. Thomas [Suisse] ; M. Vukicevic [Suisse] ; M. Nagy [Suisse] ; E. Levrat [Suisse] ; M. Bernimoulin [Suisse] ; L. Kaiser [Suisse] ; E. Roosnek [Suisse] ; J. Passweg [Suisse] ; Y. Chalandon [Suisse] | Clinical features and outcome of 2009-influenza A (H1N1) after allogeneic hematopoietic SCT |
| 000722 |
Dimpy P. Shah [États-Unis] ; Katia K. El Taoum [États-Unis] ; Jharna N. Shah [États-Unis] ; Karen J. Vigil [États-Unis] ; Javier A. Adachi [États-Unis] ; Bruno P. Granwehr [États-Unis] ; Jeffrey J. Tarrand [États-Unis] ; Issam I. Raad [États-Unis] ; Roy F. Chemaly [États-Unis] | Characteristics and Outcomes of Pandemic 2009/H1 N1 Versus Seasonal Influenza in Children With Cancer |
| 000730 |
Aureliaa. Fallo [Argentine] ; María Marta Contrini [Argentine] ; Silvina Neyro [Argentine] ; Eduardo Luis Lopez [Argentine] | CASE CHARACTERISTICS AND USE OF OSELTAMIVIR IN CHILDREN AND HOUSEHOLD CONTACTS |
| 000742 |
Nongluk Sriwilaijaroen [Thaïlande, Japon] ; Syuichi Fukumoto [Japon] ; Kenji Kumagai [Japon] ; Hiroaki Hiramatsu [Japon] ; Takato Odagiri [Japon] ; Masato Tashiro [Japon] ; Yasuo Suzuki [Japon] | Antiviral effects of Psidium guajava Linn. (guava) tea on the growth of clinical isolated H1 N1 viruses: Its role in viral hemagglutination and neuraminidase inhibition |
| 000744 |
Ha T. Nguyen [États-Unis] ; Alma A. Trujillo [États-Unis] ; Tiffany G. Sheu [États-Unis] ; Marnie Levine [États-Unis] ; Vasiliy P. Mishin [États-Unis] ; Michael Shaw [États-Unis] ; Edwin W. Ades [États-Unis] ; Alexander I. Klimov [États-Unis] ; Alicia M. Fry [États-Unis] ; Larisa V. Gubareva [États-Unis] | Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States |
| 000751 |
Sergey A. Tarasov [Russie] ; Vladimir V. Zarubaev [Russie] ; Evgeniy A. Gorbunov [Russie] ; Svetlana A. Sergeeva [Russie] ; Oleg I. Epstein [Russie] | Activity of ultra-low doses of antibodies to gamma-interferon against lethal influenza A(H1N1)2009 virus infection in mice |
| 000824 |
Ashley N. Brown [États-Unis] ; James J. Mcsharry [États-Unis] ; QINGMEI WENG [États-Unis] ; Jonathan R. Adams [États-Unis] ; Robert Kulawy [États-Unis] ; George L. Drusano [États-Unis] | Zanamivir, at 600 Milligrams Twice Daily, Inhibits Oseltamivir-Resistant 2009 Pandemic H1N1 Influenza Virus in an In Vitro Hollow-Fiber Infection Model System |
| 000864 |
Diego Viasus [Espagne] ; José Ram N Pano-Pardo [Espagne] ; Jer Nimo Pachon [Espagne] ; Melchor Riera [Espagne] ; Francisco Lopez-Medrano [Espagne] ; Antoni Payeras [Espagne] ; M. Carmen Farinas [Espagne] ; Asunci N Moreno [Espagne] ; Jesús Rodriguez-Bano [Espagne] ; José Antonio Oteo [Espagne] ; Lucia Ortega [Espagne] ; Julián Torre-Cisneros [Espagne] ; Ferrán Segura [Espagne] ; Jordi Carratala [Espagne] | Timing of Oseltamivir Administration and Outcomes in Hospitalized Adults With Pandemic 2009 Influenza A(H1N1) Virus Infection |
| 000868 |
Susan Bennett [Royaume-Uni] ; Rory N. Gunson [Royaume-Uni] ; Alasdair Maclean [Royaume-Uni] ; Rhona Miller [Royaume-Uni] ; William F. Carman [Royaume-Uni] | The validation of a real-time RT-PCR assay which detects influenza A and types simultaneously for influenza A H1N1 (2009) and oseltamivir-resistant (H275Y) influenza A H1N1(2009) |
| 000901 |
Aysegul Zenciroglu [Turquie] ; Ahmet Afsin Kundak [Turquie] ; Mustafa Aydin [Turquie] ; Nurullah Okumus [Turquie] ; Arzu Dursun [Turquie] ; Mehmet Sah Ipek [Turquie] ; Belma Saygili Karagol [Turquie] ; Nilay Hakan [Turquie] ; Nazmiye Nilgun Karadag [Turquie] ; Ayse Basak Altas [Turquie] ; Gulay Korukluoglu [Turquie] | Swine influenza A (H1N1) virus infection in infants |
| 000916 |
Jack K. Homer | Simulated Docking of Zanamivir with the 1918 Pandemic Strain Influenza A/H1N1 Neuraminidase Active Site |
| 000917 |
Jack K. Horner | Simulated Docking of Oseltamivir with the 1918 Pandemic Strain Influenza A/H1N1 Neuraminidase Active Site |
| 000918 |
Jack K. Horner | Simulated Docking of Oseltamivir with the 1918 Pandemic Strain Influenza A/H1N1 "Zanamivir-Conformed" Neuraminidase Active Site |
| 000919 |
Jack K. Horner | Simulated Docking of Oseltamivir with an Avian Influenza (A/H5N1) Neuraminidase Active Site |
| 000940 |
Michael Schatz [États-Unis] ; Christina D. Chambers [États-Unis] ; Kenneth Lyons Jones [États-Unis] ; Carol Louik [États-Unis] ; Allen A. Mitchell [États-Unis] | Safety of influenza immunizations and treatment during pregnancy: the Vaccines and Medications in Pregnancy Surveillance System |
| 000956 |
Jian R. Bao [États-Unis] ; Thomas K. Huard [États-Unis] ; Arelis E. Piscitelli [États-Unis] ; Praveena R. Tummala [États-Unis] ; Virginia E. Aleemi [États-Unis] ; Stephanie L. Coon [États-Unis] ; Ronald N. Master [États-Unis] ; Michael A. Lewinski [États-Unis] ; Richard B. Clark [États-Unis] | Reverse-transcription polymerase chain reaction/pyrosequencing to characterize neuraminidase H275 residue of influenza A 2009 H1N1 virus for rapid and specific detection of the viral oseltamivir resistance marker in a clinical laboratory |
| 000966 |
Marie-Eve Hamelin [Canada] ; Mariana Baz [Canada] ; Xavier Bouhy [Canada] ; Edith Beaulieu [Canada] ; Karen Dube [Canada] ; Corey Mallett [Canada] ; Guy Boivin [Canada] | Reduced airborne transmission of oseltamivir-resistant pandemic A/H1N1 virus in ferrets |
| 000974 |
Mina Nakauchi [Japon] ; Makoto Ujike [Japon] ; Masatsugu Obuchi [Japon] ; Emi Takashita [Japon] ; Ikuyo Takayama [Japon] ; Miho Ejima [Japon] ; Kunihiro Oba [Japon] ; Nami Konomi [Japon] ; Takato Odagiri [Japon] ; Masato Tashiro [Japon] ; Tsutomu Kageyama [Japon] | Rapid Discrimination of Oseltamivir-Resistant 275Y and -Susceptible 275H Substitutions in the Neuraminidase Gene of Pandemic Influenza A/H1N1 2009 Virus by Duplex One-Step RT-PCR Assay |
| 000999 |
Laura G. Greer [États-Unis] ; Richard D. Leff [États-Unis] ; Vanessa Laibl Rogers [États-Unis] ; Scott W. Roberts [États-Unis] ; George H. Jr Mccracken [États-Unis] ; George D. Jr Wendel [États-Unis] ; Jeanne S. Sheffield [États-Unis] | Pharmacokinetics of oseltamivir according to trimester of pregnancy |
| 000A22 |
Daniel W. Brookes [Royaume-Uni] ; Shahajahan Miah [Royaume-Uni] ; Angie Lackenby [Royaume-Uni] ; Lorian Hartgroves [Royaume-Uni] ; Wendy S. Barclay [Royaume-Uni] | Pandemic H1N1 2009 influenza virus with the H275Y oseltamivir resistance neuraminidase mutation shows a small compromise in enzyme activity and viral fitness |
| 000A29 |
SAWAN KANCHANA [Thaïlande] ; SUPANNAKHON KANCHANA [Thaïlande] ; CHARAS CHUNTRAKUL [Thaïlande] ; KUMTHORN MALATHUM [Thaïlande] ; SLINPORN PRACHAYANGPRECHA [Thaïlande] ; YONG POOVORAWAN [Thaïlande] | Pandemic (H1N1) 2009 virus infection: Persistent viral shedding after Oseltamivir treatment |
| 000A36 |
Antoni Noguera-Julian [Espagne] ; Ana C. Provens [Espagne] ; Pere Soler-Palacin [Espagne] ; Maria Espiau [Espagne] ; Antonio Mur [Espagne] ; María Mendez [Espagne] ; Clàudia Fortuny [Espagne] | PANDEMIC INFLUENZA A (2009 H1N1) IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CATALAN CHILDREN |
| 000A40 |
Juan Ledesma [Espagne] ; Diego Vicente [Espagne] ; Francisco Pozo [Espagne] ; Gustavo Cilla [Espagne] ; Sonia Perez Castro [Espagne] ; Jonathan Suarez Fernandez [Espagne] ; Mercedes Perez Ruiz [Espagne] ; José Maria Navarro [Espagne] ; Juan Carlos Galan [Espagne] ; Mirian Fernandez [Espagne] ; Jordi Reina [Espagne] ; Amparo Larrauri [Espagne] ; Maria Teresa Cuevas [Espagne] ; Inmaculada Casas [Espagne] ; Pilar Perez Brena [Espagne] | Oseltamivir-resistant pandemic influenza a (H1N1) 2009 viruses in Spain |
| 000A41 |
Adam Meijer [Pays-Bas] ; Marcel Jonges [Pays-Bas] ; Floor Abbink [Pays-Bas] ; Wim Ang [Pays-Bas] ; Janko Van Beek [Pays-Bas] ; Matthias Beersma [Pays-Bas] ; Peter Bloembergen [Pays-Bas] ; Charles Boucher [Pays-Bas] ; Eric Claas [Pays-Bas] ; Gé Donker [Pays-Bas] ; Rianne Van Gageldonk-Lafeber [Pays-Bas] ; Leslie Isken [Pays-Bas] ; Arjan De Jong [Pays-Bas] ; Aloys Kroes [Pays-Bas] ; Sander Leenders [Pays-Bas] ; Mariken Van Der Lubben [Pays-Bas] ; Ellen Mascini [Pays-Bas] ; Bert Niesters [Pays-Bas] ; Jan Jelrik Oosterheert [Pays-Bas] ; Albert Osterhaus [Pays-Bas] ; Rob Riesmeijer [Pays-Bas] ; Annelies Riezebos-Brilman [Pays-Bas] ; Martin Schutten [Pays-Bas] ; Fre Sebens [Pays-Bas] ; Foekje Stelma [Pays-Bas] ; Corien Swaan [Pays-Bas] ; Aura Timen [Pays-Bas] ; Annemarie Van T Veen [Pays-Bas] ; Erhard Van Der Vries [Pays-Bas] ; Margreet Te Wierik [Pays-Bas] ; Marion Koopmans [Pays-Bas] | Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010 |
| 000A48 |
Nahed M. Abdel-Haq [États-Unis] ; Basim I. Asmar [États-Unis] | Novel Swine-Origin Influenza A: The 2009 H1N1 Influenza Virus : INFECTIONS OLD AND NEW-I |
| 000A77 |
Mas Suhaila [Singapour] ; Julian W. Tang [Singapour] ; HONG KAI LEE [Singapour] ; CUI LIN [Singapour] ; Paul A. Tambyah [Singapour] ; HUI KIM YAP [Singapour] ; SENG HOCK QUAK [Singapour] ; Evelyn S. C. Koay [Singapour] | MIXTURES OF OSELTAMIVIR-SENSITIVE AND -RESISTANT PANDEMIC INFLUENZA A/H1N1/2009 VIRUSES IN IMMUNOCOMPROMISED HOSPITALIZED CHILDREN |
| 000A91 |
Vernonj. Lee [Singapour, Australie] ; Jonathan Yap [Singapour] ; Sebastian Maurer-Stroh [Singapour] ; Raphael T. C. Lee [Singapour] ; Frank Eisenhaber [Singapour] ; Joshua K. Tay [Singapour] ; PEI JUN TING [Singapour] ; JIN PHANG LOH [Singapour] ; Christopher W. Wong [Singapour] ; BOON HUAN TAN [Singapour] ; Evelyn S. C. Koay [Singapour] ; Paul M. Kelly [Australie] ; Martin L. Hibberd [Singapour] | Investigation of causes of oseltamivir chemoprophylaxis failures during influenza A (H1N1-2009) outbreaks |
| 000B14 |
C. Siau [Singapour] ; A. Tee [Singapour] ; V. Au [Singapour] ; J. Raghuram [Singapour] ; H. M. L. Oh [Singapour] ; K. M. Fock [Singapour] ; E. K. Teo [Singapour] | Influenza A H1N1 (2009): clinical spectrum of disease among adult patients admitted to a regional hospital in Singapore |
| 000B32 |
Alejandro Rodriguez [Espagne] ; Emili Diaz [Espagne] ; Ignacio Martin-Loeches [Espagne] ; Alberto Sandiumenge [Espagne] ; Laura Canadell [Espagne] ; Juan J. Diaz [Espagne] ; Juan C. Figueira [Espagne] ; Asuncion Marques [Espagne] ; Francisco Alvarez-Lerma [Espagne] ; Jordi Valles [Espagne] ; Bárbara Baladin [Espagne] ; Fernando Garcia-Lopez [Espagne] ; Borja Suberviola [Espagne] ; Rafael Zaragoza [Espagne] ; Sandra Trefler [Espagne] ; Juan Bonastre [Espagne] ; Jose Blanquer [Espagne] ; Jordi Rello [Espagne] | Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A |
| 000B51 |
Yasushi Suzuki [Japon] ; Reiko Saito [Japon] ; Isamu Sato [Japon] ; Hassan Zaraket [Japon] ; Makoto Nishikawa [Japon] ; Tsutomu Tamura [Japon] ; Clyde Dapat [Japon] ; Isolde Caperig-Dapat [Japon] ; Tatiana Baranovieh [Japon] ; Takako Suzuki [Japon] ; Hiroshi Suzuki [Japon] | Identification of Oseltamivir Resistance among Pandemic and Seasonal Influenza A (H1N1) Viruses by an His275Tyr Genotyping Assay Using the Cycling Probe Method |
| 000B78 |
Susanne C. Duwe [Allemagne] ; Marianne Wedde [Allemagne] ; Patricia Birkner [Allemagne] ; Brunhilde Schweiger [Allemagne] | Genotypic and phenotypic resistance of pandemic A/H1N1 influenza viruses circulating in Germany |
| 000B89 |
Eskild Petersen [Danemark] ; Dorte B. Keld [Danemark] ; Svend Ellermann-Eriksen [Danemark] ; Sophie Gubbels [Suède, Danemark] ; Susanne Ilkjaer [Danemark] ; S Ren Jensen-Fangel [Danemark] ; Christian Lindskov [Danemark] | Failure of combination oral oseltamivir and inhaled zanamivir antiviral treatment in ventilator- and ECMO-treated critically ill patients with pandemic influenza A (H1N1)v |
| 000C11 |
Catherine Moore [Royaume-Uni] ; Monica Galiano [Royaume-Uni] ; Angie Lackenby [Royaume-Uni] ; Tamer Abdelrahman [Royaume-Uni] ; Rosemary Barnes [Royaume-Uni] ; Meirion R. Evans [Royaume-Uni] ; Christopher Fegan [Royaume-Uni] ; Susannah Froude [Royaume-Uni] ; Mark Hastings [Royaume-Uni] ; Steven Knapper [Royaume-Uni] ; Emma Litt [Royaume-Uni] ; Nicola Price [Royaume-Uni] ; Roland Salmon [Royaume-Uni] ; Mark Temple [Royaume-Uni] ; Eleri Davies [Royaume-Uni] | Evidence of Person-to-Person Transmission of Oseltamivir-Resistant Pandemic Influenza A(H1N1) 2009 Virus in a Hematology Unit |
| 000C13 |
Simona Puzelli [Italie] ; Marzia Facchini [Italie] ; Angela Di Martino [Italie] ; Concetta Fabiani [Italie] ; Angie Lackenby [Royaume-Uni] ; Maria Zambon [Royaume-Uni] ; Isabella Donatelli [Italie] | Evaluation of the antiviral drug susceptibility of influenza viruses in Italy from 2004/05 to 2009/10 epidemics and from the recent 2009 pandemic |
| 000C38 |
Christian Renaud [États-Unis] ; Jane Kuypers [États-Unis] ; Janet A. Englund [États-Unis] | Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1 |
| 000C52 |
Anand Kumar [Canada, États-Unis] | Early versus late oseltamivir treatment in severely ill patients with 2009 pandemic influenza A (H1N1): speed is life |
| 000C56 |
SHIN NA [Corée du Sud] ; YONG PIL CHONG [Corée du Sud] ; Mi-Na Kim [Corée du Sud] ; WON YOUNG KIM [Corée du Sud] ; WON KIM [Corée du Sud] ; Sang-Bum Hong [Corée du Sud] ; Chae-Man Lim [Corée du Sud] ; Younsuck Koh [Corée du Sud] ; Ji-Won Kwon [Corée du Sud] ; Soo-Jong Hong [Corée du Sud] ; Sang-Oh Lee [Corée du Sud] ; Sang-Ho Choi [Corée du Sud] ; YANG SOO KIM [Corée du Sud] ; JUN HEE WOO [Corée du Sud] ; Sung-Han Kim [Corée du Sud] | Duration of Viral Shedding in Patients Admitted to Hospital With Pandemic Influenza A/H1N1 2009 Infection |
| 000C71 |
Sallene Wong [Canada] ; Kanti Pabbaraju [Canada] ; Anita Wong [Canada] ; Kevin Fonseca [Canada] ; Steven J. Drews [Canada] | Development of a real-time RT-PCR assay for detection of resistance to oseltamivir in influenza A pandemic (H1N1) 2009 virus using single nucleotide polymorphism probes |
| 000C80 |
Sunchai Payungporn [Thaïlande] ; Wittaya Poomipak [Thaïlande] ; Jarika Makkoch [Thaïlande] ; Pornpimol Rianthavorn [Thaïlande] ; Apiradee Theamboonlers [Thaïlande] ; Yong Poovorawan [Thaïlande] | Detection of oseltamivir sensitive/resistant strains of pandemic influenza A virus (H1N1) from patients admitted to hospitals in Thailand |
| 000C86 |
Elodie Ghedin [États-Unis] ; Jennifer Laplante [États-Unis] ; Jay Depasse [États-Unis] ; David E. Wentworth [États-Unis] ; Roberto P. Santos [États-Unis] ; Martha L. Lepow [États-Unis] ; Joanne Porter [États-Unis] ; Kathleen Stellrecht [États-Unis] ; XUDONG LIN [États-Unis] ; Darwin Operario [États-Unis] ; Sara Griesemer [États-Unis] ; Adam Fitch [États-Unis] ; Rebecca A. Halpin [États-Unis] ; Timothy B. Stockwell [États-Unis] ; David J. Spiro [États-Unis] ; Edward C. Holmes [États-Unis] ; Kirsten St. George [États-Unis] | Deep Sequencing Reveals Mixed Infection with 2009 Pandemic Influenza A (H1N1) Virus Strains and the Emergence of Oseltamivir Resistance |
| 000C89 |
Cristian Launes [Espagne] ; Juan-José Garcia-Garcia [Espagne] ; Iolanda Jordan [Espagne] ; Aina Martinez-Planas [Espagne] ; Laura Selva [Espagne] ; Carmen Munoz-Almagro [Espagne] | DELAYS IN STARTING TREATMENT WITH OSELTAMIVIR WERE ASSOCIATED WITH A MORE SEVERE DISEASE |
| 000D24 |
Gulam Khandaker [Australie] ; Yvonne Zurynski [Australie] ; David Lester-Smith [Australie] ; Alison Kesson [Australie] ; Leon Heron [Australie] ; Dominic E. Dwyer [Australie] ; Elizabeth J. Elliott [Australie] ; Robert Booy [Australie] | Clinical features, oseltamivir treatment and outcome in infants aged <12 months with laboratory-confirmed influenza A in 2009 |
| 000D42 |
TRONG TUAN DAO [Corée du Sud] ; PHI HUNG NGUYEN [Corée du Sud] ; HONG SIK LEE [Corée du Sud] ; Eunhee Kim [Corée du Sud] ; Junsoo Park [Corée du Sud] ; SEONG IL LIM [Corée du Sud] ; WON KEUN OH [Corée du Sud] | Chalcones as novel influenza A (H1N1) neuraminidase inhibitors from Glycyrrhiza inflate |
| 000D60 |
Elena A. Govorkova [États-Unis] ; Bindumadhav M. Marathe [États-Unis] ; Ashley Prevost [États-Unis] ; Jerold E. Rehg [États-Unis] ; Robert G. Webster [États-Unis] | Assessment of the efficacy of the neuraminidase inhibitor oseltamivir against 2009 pandemic H1N1 influenza virus in ferrets |
| 000D89 |
JIE ZHOU [République populaire de Chine] ; LIRONG ZOU [République populaire de Chine] ; XIN ZHANG [République populaire de Chine] ; JIAZHENG LIAO [République populaire de Chine] ; HANZHONG NI [République populaire de Chine] ; NIANMEI HOU [République populaire de Chine] ; YAJING WANG [République populaire de Chine] ; HUI LI [République populaire de Chine] ; JIE WU [République populaire de Chine] ; Marcel Jonges [Pays-Bas] ; Adam Meijer [Pays-Bas] ; Marion Koopmans [Pays-Bas] ; CHANGWEN KE [République populaire de Chine] | Adamantane- and Oseltamivir-Resistant Seasonal A (H1N1) and Pandemic A (H1N1) 2009 Influenza Viruses in Guangdong, China, during 2008 and 2009 |
| 000E01 |
Y. H. Leung [Hong Kong] ; M. P. Li [Hong Kong] ; S. K. Chuang [Hong Kong] | A school outbreak of pandemic (H1N1) 2009 infection: assessment of secondary household transmission and the protective role of oseltamivir |
| 000E11 |
Yi-Mo Deng [Australie] ; Natalie Caldwell [Australie] ; Aeron Hurt [Australie] ; Tim Shaw [Australie] ; Anne Kelso [Australie] ; Glenys Chidlow [Australie] ; Simon Williams [Australie] ; David Smith [Australie] ; Ian Barr [Australie] | A comparison of pyrosequencing and neuraminidase inhibition assays for the detection of oseltamivir-resistant pandemic influenza A(H1N1 ) 2009 viruses |
| 000E66 |
Déborah Talmud [France] ; Joël Cousson [France] ; Nicolas Leveque [France] ; Alain Leon [France] ; Laurent Andreoletti [France] | À propos de deux cas de pneumonie à influenza virus A/H1N1v pris en charge en réanimation au CHU de Reims durant l'hiver 2009 |
| 000F14 |
Daniel E. Dulek [États-Unis] ; John V. Williams [États-Unis] ; C. Buddy Creech [États-Unis] ; Alynna K. Schulert [États-Unis] ; Haydar A. Frangoul [États-Unis] ; Jennifer Domm [États-Unis] ; Mark R. Denison [États-Unis] ; James D. Chappell [États-Unis] | Use of Intravenous Zanamivir after Development of Oseltamivir Resistance in a Critically Ill Immunosuppressed Child Infected with 2009 Pandemic Influenza A (H1N1) Virus |
| 000F21 |
Matthew E. Falagas [Grèce, États-Unis] ; Evridiki K. Vouloumanou [Grèce] ; Evagelia Baskouta [Grèce] ; Petros I. Rafailidis [Grèce] ; Kostantinos Polyzos [Grèce] ; Jordi Rello [Espagne] | Treatment options for 2009 H1N1 influenza: evaluation of the published evidence |
| 000F25 |
BINH KHANH MAI [Viêt Nam] ; MAN HOANG VIET [Pologne] ; MAI SUAN LI [Pologne] | Top Leads for Swine Influenza A/H1N1 Virus Revealed by Steered Molecular Dynamics Approach |
| 000F33 |
Glenys R. Chidlow [Australie] ; Gerald B. Harnett [Australie] ; Simon H. Williams [Australie] ; Simone S. Tempone [Australie] ; David J. Speers [Australie] ; Aeron C. Hurt [Australie] ; Yi-Mo Deng [Australie] ; David W. Smith [Australie] | The detection of oseltamivir-resistant pandemic influenza A/H1N1 2009 viruses using a real-time RT-PCR assay |
| 000F36 |
Iris W. Li [Hong Kong] ; Ivan F. Hung [Hong Kong] ; Kelvin K. To [Hong Kong] ; Kwok-Hung Chan [Hong Kong] ; Samson S. Y. Wong [Hong Kong] ; Jasper F. Chan [Hong Kong] ; Vincent C. Cheng [Hong Kong] ; Owen T. Tsang [Hong Kong] ; Sik-To Lai [Hong Kong] ; Yu-Lung Lau [Hong Kong] ; Kwok-Yung Yuen [Hong Kong] | The Natural Viral Load Profile of Patients With Pandemic 2009 Influenza A(H1N1) and the Effect of Oseltamivir Treatment |
| 000F44 |
Ronald B. Moss [États-Unis] ; Richard T. Davey [États-Unis] ; Roy T. Steigbigel [États-Unis] ; FANG FANG [États-Unis] | Targeting pandemic influenza: a primer on influenza antivirals and drug resistance |
| 000F59 |
Nao Nukiwa [Japon] ; Akira Suzuki [Japon] ; Yuki Furuse [Japon] ; Kozue Shimabukuro [Japon] ; Takashi Odagiri [Japon] ; Irona Khandaker [Japon] ; Hitoshi Oshitani [Japon] | Simplified screening method for detecting oseltamivir resistant pandemic influenza A (H1 N1 ) 2009 virus by a RT-PCR/restriction fragment length polymorphism assay |
| 000F72 |
Andrés Anton [Espagne] ; Ana Alicia Lopez-Iglesias [Espagne] ; Teresa Tortola [Espagne] ; Isabel Ruiz-Camps [Espagne] ; Pau Abrisqueta [Espagne] ; Lluis Llopart [Espagne] ; María Angeles Marcos [Espagne] ; Miguel Julian Martinez [Espagne] ; Griselda Tudo [Espagne] ; Francesc Bosch [Espagne] ; Albert Pahissa [Espagne] ; Maria Teresa Jimenez De Anta [Espagne] ; Tomàs Pumarola [Espagne] | Selection and viral load kinetics of an oseltamivir-resistant pandemic influenza A (H1N1) virus in an immunocompromised patient during treatment with neuraminidase inhibitors |
| 000F97 |
David Reddy [Suisse] | Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir |
| 001002 |
Ha T. Nguyen [États-Unis] ; Alicia M. Fry [États-Unis] ; P. Ann Loveless [États-Unis] ; Alexander I. Klimov [États-Unis] ; Larisa V. Gubareva [États-Unis] | Recovery of a Multidrug-Resistant Strain of Pandemic Influenza A 2009 (H1N1) Virus Carrying a Dual H275Y/ I223R Mutation from a Child after Prolonged Treatment with Oseltamivir |
| 001014 |
Matthew J. Memoli [États-Unis] ; Rachel J. Hrabal [États-Unis] ; Arash Hassantoufighi [États-Unis] ; Maryna C. Eichelberger [États-Unis] ; Jeffery K. Taubenberger [États-Unis] | Rapid Selection of Oseltamivir-and Peramivir-Resistant Pandemic H1N1 Virus during Therapy in 2 Immunocompromised Hosts |
| 001046 |
Brian E. Davies [États-Unis] | Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations |
| 001049 |
Ankit Parakh [Inde] ; Amit Kumar [Inde] ; Virendra Kumar [Inde] ; ASHOK KUMAR DUTTA [Inde] ; Shashi Khare [Inde] | Pediatric Hospitalizations Associated with 2009 Pandemic Influenza A (H1N1): An Experience from a Tertiary Care Center in North India |
| 001051 |
Sanjay Mukhopadhyay [États-Unis] ; Abraham T. Philip [États-Unis] ; Robert Stoppacher [États-Unis] | Pathologic Findings in Novel Influenza A (H1N1) Virus ("Swine Flu") Infection: Contrasting Clinical Manifestations and Lung Pathology in Two Fatal Cases |
| 001062 |
Cristian Launes [Espagne] ; Susana Rives [Espagne] ; Albert Catala [Espagne] ; Rubén Berrueco [Espagne] ; Teresa Toll [Espagne] ; Mireia Camos [Espagne] ; Carmen Munoz-Almagro [Espagne] ; Juan J. Garcia-Garcia [Espagne] ; Jesús Estella [Espagne] | Pandemic influenza A (2009 H1 N1) in children with acute lymphoblastic leukaemia |
| 001072 |
Emre Tekgündüz [Turquie] ; Meltem Kurt Yüksel [Turquie] ; Ci Gbreve Dem Erbay [Turquie] ; Bilgin Aribas [Turquie] ; Ci Gbreve Dem Özdilekcan [Turquie] ; Hülya Arslan [Turquie] ; Serife Kocubaba [Turquie] ; Itir Demiriz [Turquie] ; Ay Egül Tetik [Turquie] ; Kemal Arda [Turquie] ; Fevzi Altuntas [Turquie] | Pandemic 2009 H1 N1 Influenza in Patients with Hematopoietic Stem Cell Transplantation and Hematologic Malignancy: Single Center Experience |
| 001088 |
David J. Speers [Australie] ; Simon H. Williams [Australie] ; Mary Pinder [Australie] ; Harry R. Moody [Australie] ; Aeron C. Hurt [Australie] ; David W. Smith [Australie] | Oseltamivir-resistant pandemic (H 1 N 1) 2009 influenza in a severely ill patient: the first Australian case |
| 001089 |
A. C. Hurt [Australie] ; Y. M. Deng [Australie] ; J. Ernest [Australie] ; N. Caldwell [Australie] ; L. Leang [Australie] ; P. Iannello [Australie] ; N. Komadina [Australie] ; R. Shaw [Australie] ; D. Smith [Australie] ; D. E. Dwyer [Australie] ; A. R. Tramontana [Australie] ; R. T. Lin [Singapour] ; K. Freeman [Australie] ; A. Kelso [Australie] ; I. G. Barr [Australie] | Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1)2009 pandemic in the Asia-Pacific region, March 2009 to March 2010 |
| 001090 |
P. A. Chan [États-Unis] ; N. T. Connell [États-Unis] ; A. M. Gabonay [États-Unis] ; B. Westley [États-Unis] ; J. M. Larkin [États-Unis] ; S. P. Larosa [États-Unis] ; K. Chapin [États-Unis] ; L. Mermel [États-Unis] | Oseltamivir-resistant 2009-2010 pandemic influenza A (H1N1) in an immunocompromised patient |
| 001091 |
Susanna Esposito [Italie] ; Claudio G. Molteni [Italie] ; Carla Colombo [Italie] ; Cristina Daleno [Italie] ; Valeria Dacco [Italie] ; Angie Lackenby [Royaume-Uni] ; Nicola Principi [Italie] | Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection |
| 001092 |
Christopher W. Seibert [États-Unis] ; Michael Kaminski [Allemagne] ; Jennifer Philipp [Allemagne] ; Dennis Rubbenstroth [Allemagne] ; Randy A. Albrecht [États-Unis] ; Folker Schwalm [Allemagne] ; Silke Stertz [États-Unis] ; Rafael A. Medina [États-Unis] ; Georg Kochs [Allemagne] ; Adolfo Garcia-Sastre [États-Unis] ; Peter Staeheli [Allemagne] ; Peter Palese [États-Unis] | Oseltamivir-Resistant Variants of the 2009 Pandemic H1N1 Influenza A Virus Are Not Attenuated in the Guinea Pig and Ferret Transmission Models |
| 001093 |
Regina Dutkowski [États-Unis] | Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients |
| 001094 |
James R. Smith [Suisse] | Oseltamivir in human avian influenza infection |
| 001095 |
Nicolas Widmer [Suisse] ; Pascal Meylan [Suisse] ; Anton Ivanyuk [Suisse] ; Manel Aouri [Suisse] ; Laurent A. Decosterd [Suisse] ; Thierry Buclin [Suisse] | Oseltamivir in Seasonal, Avian H5N1 and Pandemic 2009 A/H1N1 Influenza: Pharmacokinetic and Pharmacodynamic Characteristics |
| 001096 |
Vernon J. Lee [Singapour, Australie] ; Jonathan Yap [Singapour] ; Alex R. Cook [Singapour] ; Mark I. Chen [Singapour] ; Joshua K. Tay [Singapour] ; BOON HUAN TAN [Singapour] ; JIN PHANG LOH [Singapour] ; SEOK WEI CHEW [Singapour] ; WEE HONG KOH [Singapour] ; Raymond Lin [Singapour] ; LIN CUI [Singapour] ; Charlie W. H. Lee [Singapour] ; Wing-Kin Sung [Singapour] ; Christopher W. Wong [Singapour] ; Martin L. Hibberd [Singapour] ; WEE LEE KANG [Singapour] ; BENJAMIN SEET [Singapour] ; Paul A. Tambyah [Singapour] | Oseltamivir Ring Prophylaxis for Containment of 2009 H1N1 Influenza Outbreaks |
| 001097 |
Gopal C. Ghosh [Japon] ; Norihide Nakada [Japon] ; Naoyuki Yamashita [Japon] ; Hiroaki Tanaka [Japon] | Oseltamivir Carboxylate, the Active Metabolite of Oseltamivir Phosphate (Tamiflu), Detected in Sewage Discharge and River Water in Japan |
| 001101 |
Michèle Ottmann [France] ; Maude Bouscambert Duchamp [France] ; Jean-Sebastien Casalegno [France] ; Emilie Frobert [France] ; Vincent Moules [France] ; Olivier Ferraris [France] ; Martine Valette [France] ; Vanessa Escuret [France] ; Bruno Lina [France] | Novel influenza A(H1N1) 2009 in vitro reassortant viruses with oseltamivir resistance |
| 001192 |
Darwin J. Operario [États-Unis] ; Michael J. Moser [États-Unis] ; Kirsten St. George [États-Unis] | Highly Sensitive and Quantitative Detection of the H274Y Oseltamivir Resistance Mutation in Seasonal A/H1N1 Influenza Virus |
| 001200 |
Adolfo Maximo Quispe-Laime [Argentine] ; Jonas Daniel Bracco [Argentine] ; Patricia Alejandra Barberio [Argentine] ; Claudio German Campagne [Argentine] ; Ver Nica Edith Rolfo [Argentine] ; Reba Umberger [États-Unis] ; Gianfranco Umberto Meduri [États-Unis] | H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment |
| 001201 |
Adolfo Maximo Quispe-Laime [Argentine] ; Jonas Daniel Bracco [Argentine] ; Patricia Alejandra Barberio [Argentine] ; Claudio German Campagne [Argentine] ; Ver Nica Edith Rolfo [Argentine] ; Reba Umberger [États-Unis] ; Gianfranco Umberto Meduri [États-Unis] | H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment |
| 001209 |
Anurodh S. Agrawal [Inde] ; Mehuli Sarkar [Inde] ; Swati Ghosh [Inde] ; Tapasi Roy [Inde] ; Sekhar Chakrabarti [Inde] ; Renu Lal [Inde] ; Akhilesh C. Mishra [Inde] ; Mandeep S. Chadha [Inde] ; Mamta Chawla-Sarkar [Inde] | Genetic characterization of circulating seasonal Influenza A viruses (2005-2009) revealed introduction of oseltamivir resistant H1N1 strains during 2009 in eastern India |
| 001213 |
Giulia Campanini [Italie] ; Antonio Piralla [Italie] ; Francesca Rovida [Italie] ; Simona Puzelli [Italie] ; Marzia Facchini [Italie] ; Franco Locatelli [Italie] ; Lorenzo Minoli [Italie] ; Elena Percivalle [Italie] ; Isabella Donatelli [Italie] ; Fausto Baldanti [Italie] | First case in Italy of acquired resistance to oseltamivir in an immunocompromised patient with influenza A/H1N1v infection |
| 001234 |
E. Van Der Vries [Pays-Bas] ; M. Jonges [Pays-Bas] ; S. Herfst [Pays-Bas] ; J. Maaskant [Pays-Bas] ; A. Van Der Linden [Pays-Bas] ; J. Guldemeester [Pays-Bas] ; G. I. Aron [Pays-Bas] ; T. M. Bestebroer [Pays-Bas] ; M. Koopmans [Pays-Bas] ; A. Meijer [Pays-Bas] ; R. A. M. Fouchier [Pays-Bas] ; A. D. M. E. Osterhaus [Pays-Bas] ; C. A. Boucher [Pays-Bas] ; M. Schutten [Pays-Bas] | Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1 ) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase |
| 001246 |
Laura E. Valinotto [Argentine] ; Roberto A. Diez [Argentine] ; Paola R. Barrero [Argentine] ; Julio A. Farias [Argentine] ; Eduardo L. Lopez [Argentine] ; Alicia S. Mistchenko [Argentine] | Emergence of intratreatment resistance to oseltamivir in pandemic influenza A H1N1 2009 virus |
| 001251 |
Li M. Ling [Singapour] ; Angela L. Chow [Singapour] ; David C. Lye [Singapour] ; Adriana S. Tan [Singapour] ; Prabha Krishnan [Singapour] ; LIN CUI [Singapour] ; Nwe N. Win [Singapour] ; Monica Chan [Singapour] ; Poh L. Lim [Singapour] ; Cheng C. Lee [Singapour] ; Yee S. Leo [Singapour] | Effects of Early Oseltamivir Therapy on Viral Shedding in 2009 Pandemic Influenza A (H1N1) Virus Infection |
| 001260 |
Ji-Rong Yang [Taïwan] ; Yuan-Pin Huang [Taïwan] ; Yu-Cheng Lin [Taïwan] ; Chun-Hui Su [Taïwan] ; Chuan-Yi Kuo [Taïwan] ; Li-Ching Hsu [Taïwan] ; Ho-Sheng Wu [Taïwan] ; Ming-Tsan Liu [Taïwan] | Early findings of oseltamivir-resistant pandemic (H1N1) 2009 influenza A viruses in Taiwan |
| 001264 |
David A. Boltz [États-Unis] ; Jerry R. Jr Aldridge [États-Unis] ; Robert G. Webster [États-Unis] ; Elena A. Govorkova [États-Unis] | Drugs in Development for Influenza |
| 001276 |
C. Renaud [États-Unis] ; J. Kuypers [États-Unis] ; L. Corey [États-Unis] | Diagnostic accuracy of an allele-specific reverse transcriptase-PCR assay targeting the H275Y oseltamivir resistant mutation in 2009 pandemic influenza A/H1N1 virus |
| 001280 |
James B. Mahony [Canada] ; Sylvia Chong [Canada] ; Kathy Luinstra [Canada] ; Astrid Petrich [Canada] ; Marek Smieja [Canada] | Development of a novel bead-based multiplex PCR assay for combined subtyping and oseltamivir resistance genotyping (H275Y) of seasonal and pandemic H1N1 influenza A viruses |
| 001289 |
BIN WANG [Australie] ; Dominic E. Dwyer [Australie] ; Christopher C. Blyth [Australie] ; Maly Soedjono [Australie] ; HAIJING SHI [Australie] ; Alison Kesson [Australie] ; Mala Ratnamohan [Australie] ; Ken Mcphie [Australie] ; Anthony L. Cunningham [Australie] ; Nitin K. Saksena [Australie] | Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections |
| 001357 |
Juan Martinez Hernandez [Espagne] ; Victoria Lopez-Rodas [Espagne] ; Eduardo Costas [Espagne] | Antiviral agents: To treat or not to treat? An old dilemma revisited in light of new data from the 2009 influenza A(H1N1) pandemic |
| 001359 |
Hassan Zaraket [Japon] ; Reiko Saito [Japon] ; Rima Wakim [Liban] ; Carelle Tabet [Liban] ; Fouad Medlej [Liban] ; Mariam Reda [Liban] ; Tatiana Baranovich [Japon] ; Yasushi Suzuki [Japon] ; Clyde Dapat [Japon] ; Isolde Caperig-Dapat [Japon] ; Ghassan S. Dbaibo [Japon] ; Hiroshi Suzuki [Japon] | Antiviral Drug Susceptibilities of Seasonal Human Influenza Viruses in Lebanon, 2008-09 Season |
| 001447 |
J. Barriere [France] ; J. Otto [France] ; E. Cua [France] ; G. Coindard ; F. Peyrade [France] | Nouvelle pandémie de grippe A (H1N1): que faire pour les patients atteints d'un cancer ? |
| 001449 |
Jean-Pierre Vallee [France] ; Hélène Coignard [France] ; Marie Leruez [France] ; Olivier Lortholary [France] | Les inhibiteurs de la neuraminidase: Oseltamivir et zanamivir |
| 001496 |
Elena A. Govorkova [États-Unis] ; Natalia A. Ilyushina [États-Unis, Russie] ; Jennifer L. Mcclaren [États-Unis] ; Tri S. P. Naipospos [Indonésie] ; Bounlom Douangngeun [Laos] ; Robert G. Webster [États-Unis] | Susceptibility of Highly Pathogenic H5N1 Influenza Viruses to the Neuraminidase Inhibitor Oseltamivir Differs In Vitro and in a Mouse Model |
| 001505 |
Leanne B. Gasink [États-Unis] ; Darren R. Linkin [États-Unis] ; Neil O. Fishman [États-Unis] ; Warren B. Bilker [États-Unis] ; Mark G. Weiner [États-Unis] ; Ebbing Lautenbach [États-Unis] | Stockpiling Drugs for an Avian Influenza Outbreak : Examining the Surge in Oseltamivir Prescriptions During Heightened Media Coverage of the Potential for a Worldwide Pandemic |
| 001576 |
R. J. Hall [Nouvelle-Zélande] ; M. P. Peacey [Nouvelle-Zélande] ; J. C. Ralston [Nouvelle-Zélande] ; J. Bocacao [Nouvelle-Zélande] ; M. Ziki [Nouvelle-Zélande] ; W. Gunn [Nouvelle-Zélande] ; A. Quirk [Nouvelle-Zélande] ; Q. S. Huang [Nouvelle-Zélande] | PANDEMIC INFLUENZA A(H1N1)V VIRUSES CURRENTLY CIRCULATING IN NEW ZEALAND ARE SENSITIVE TO OSELTAMIVIR |
| 001584 |
Aeron C. Hurt [Australie] ; Jessica K. Holien [Australie] ; Michael W. Parker [Australie] ; Ian G. Barr [Australie] | Oseltamivir Resistance and the H274Y Neuraminidase Mutation in Seasonal, Pandemic and Highly Pathogenic Influenza Viruses |
| 001591 |
S. Burrel [France] ; L. Roncin [France] ; M. E. Lafon [France] ; H. Fleury [France] | OSELTAMIVIR SUSCEPTIBILITY IN SOUTH-WESTERN FRANCE DURING THE 2007-8 AND 2008-9 INFLUENZA EPIDEMICS AND THE ONGOING INFLUENZA PANDEMIC 2009 |
| 001592 |
A. Kitching [Suède, Royaume-Uni] ; A. Roche [Royaume-Uni] ; S. Balasegaram [Royaume-Uni] ; R. Heathcock [Royaume-Uni] ; H. Maguire [Royaume-Uni] | OSELTAMIVIR ADHERENCE AND SIDE EFFECTS AMONG CHILDREN IN THREE LONDON SCHOOLS AFFECTED BY INFLUENZA A(H1N1)v, MAY 2009 - AN INTERNET-BASED CROSS-SECTIONAL SURVEY |
| 001598 |
Lain Stephenson [Royaume-Uni] ; Jane Democratis [Royaume-Uni] ; Angie Lackenby [Royaume-Uni] ; Teresa Mcnally [Royaume-Uni] ; James Smith [Suisse] ; Manish Pareek [Royaume-Uni] ; Joanna Ellis [Royaume-Uni] ; Alison Bermingham [Royaume-Uni] ; Karl Nicholson [Royaume-Uni] ; Maria Zambon [Royaume-Uni] ; Arnold S. Monto [États-Unis] | Neuraminidase Inhibitor Resistance after Oseltamivir Treatment of Acute Influenza A and B in Children. Commentary |
| 001673 |
ZEYU LIU [République populaire de Chine] ; ZHONGMIN GUO [République populaire de Chine] ; GUOLING WANG [République populaire de Chine] ; DINGMEI ZHANG [République populaire de Chine] ; HONGXUAN HE [République populaire de Chine] ; GUOWEI LI [République populaire de Chine] ; YUGE LIU [République populaire de Chine] ; Denise Higgins [États-Unis] ; Aoiffe Walsh [États-Unis] ; Leo Shanahan-Prendergast [États-Unis] ; JIAHAI LU [République populaire de Chine] | Evaluation of the efficacy and safety of a statin/caffeine combination against HSN1, H3N2 and H1N1 virus infection in BALB/c mice |
| 001707 |
M. Jonges [Pays-Bas] ; I. M. Van Der Lubben [Pays-Bas] ; F. Dijkstra [Pays-Bas] ; L. Verhoef [Pays-Bas] ; M. Koopmans [Pays-Bas] ; A. Meijer [Pays-Bas] | Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005-2008 |
| 001713 |
Megan C. Steain [Australie] ; Dominic E. Dwyer [Australie] ; Aeron C. Hurt [Australie] ; Chenda Kol [Australie] ; Nitin K. Saksena [Australie] ; Anthony L. Cunningham [Australie] ; BIN WANG [Australie] | Detection of influenza A H1N1 and H3N2 mutations conferring resistance to oseltamivir using rolling circle amplification |
| 001750 |
Mark Von Itzstein [Australie] ; Robin Thomson [Australie] | Anti-Influenza Drugs : The Development of Sialidase Inhibitors |
| 001827 |
Peter Bartels [Allemagne] ; Wolf Jr Von Tümpling [Allemagne] | The environmental fate of the antiviral drug oseltamivir carboxylate in different waters |
| 001862 |
Nicole M. Bouvier [États-Unis] ; Anice C. Lowen [États-Unis] ; Peter Palese [États-Unis] | Oseltamivir-Resistant Influenza A Viruses Are Transmitted Efficiently among Guinea Pigs by Direct Contact but Not by Aerosol |
| 001931 |
Arnold S. Monto [États-Unis] | Antivirals and Influenza : Frequency of Resistance |
| 001973 |
H. Gras-Masse [France] ; N. Willand [France] | Glycochimie et thérapeutique Les inhibiteurs de neuraminidase face au risque de grippe aviaire |
| 001A20 |
Phillip Andrew Reece [Australie] | Neuraminidase inhibitor resistance in influenza viruses |
| 001A23 |
K. N. Masihi [Allemagne] ; B. Schweiger [Allemagne] ; T. Finsterbusch [Allemagne] ; H. Hengel [Allemagne] | Low dose oral combination chemoprophylaxis with oseltamivir and amantadine for influenza A virus infections in mice |
| 001A43 |
J. Joseph-Charles [France] ; C. Geneste [France] ; E. Laborde-Kummer [France] ; R. Gheyouche [Algérie] ; H. Boudis [Algérie] ; J.-P. Dubost [France] | Development and validation of a rapid HPLC method for the determination of oseltamivir phosphate in Tamiflu® and generic versions |
| 001A47 |
Maarten J. Postma [Pays-Bas] ; Annoesjka Novak [Pays-Bas] ; Huib W. K. F. H. Scheijbeler [Pays-Bas, Royaume-Uni] ; Marlene Gyldmark [Suisse] ; Marianne L. L. Van Genugten [Pays-Bas] ; Jan C. Wilschut [Pays-Bas] | Cost effectiveness of oseltamivir treatment for patients with influenza-like illness who are at increased risk for serious complications of influenza : Illustration for the netherlands |
| 001A64 |
| Antiviral therapy and prophylaxis for influenza in children |
| 001A69 |
Natalia A. Ilyushina [États-Unis, Russie] ; Erich Hoffmann [États-Unis] ; Rachelle Salomon [États-Unis] ; Robert G. Webster [États-Unis] ; Elena A. Govorkova [États-Unis, Russie] | Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice |
| 001B41 |
J. S. Oxford [Royaume-Uni] ; R. Lambkin [Royaume-Uni] ; A. Elliot [Royaume-Uni] ; R. Daniels [Royaume-Uni] ; A. Sefton [Royaume-Uni] ; D. Gill [Royaume-Uni] | Scientific lessons from the first influenza pandemic of the 20th century |
| 001B51 |
Beate Sander [Canada] ; Frederick G. Hayden [États-Unis] ; Marlene Gyldmark [Suisse] ; Louis P. Jr Garrison [Suisse] | Post-exposure influenza prophylaxis with oseltamivir: cost effectiveness and cost utility in families in the UK |
| 001B53 |
Stephen M. Ford [États-Unis] ; John D. Grabenstein [États-Unis] | Pandemics, avian influenza a (H5N1), and a strategy for pharmacists |
| 001C04 |
Roland R. Regoes [Suisse] ; Sebastian Bonhoeffer [Suisse] | Emergence of drug-resistant influenza virus : Population dynamical considerations |
| 001C23 |
M. Brewster [Royaume-Uni] ; J. R. Smith [Suisse] ; R. Dutkowski [États-Unis] ; R. Robson [Nouvelle-Zélande] | Active metabolite from Tamiflu® solution is bioequivalent to that from capsule delivery in healthy volunteers : A cross-over, randomised, open-label study |
| 001C55 |
| Les antiviraux dans la grippe : Un complément à la vaccination, dans certains cas |
| 001C61 |
Hui-Ling Yen [États-Unis] ; Arnold S. Monto [États-Unis] ; Robert G. Webster [États-Unis] ; Elena A. Govorkova [États-Unis] | Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/vietnam/1203/04 influenza virus in mice |
| 001C77 |
Sandro Cinti [États-Unis] ; Carol Chenoweth [États-Unis] ; Arnold S. Monto [États-Unis] | Preparing for pandemic influenza : Should hospitals stockpile oseltamivir? |
| 001C79 |
Penelope Ward [Royaume-Uni] ; Ian Small [Royaume-Uni] ; James Smith [Suisse] ; Pia Suter [Suisse] ; Regina Dutkowski [États-Unis] | Oseltamivir (Tamiflu®) and its potential for use in the event of an influenza pandemic |
| 001D46 |
P. Wutzler [Allemagne] ; K.-D. Kossow [Allemagne] ; H. Lode [Allemagne] ; B. R. Ruf [Allemagne] ; H. Scholz [Allemagne] ; G. E. Vogel [Allemagne] | Antiviral treatment and prophylaxis of influenza in primary care: German recommendations |
